Evidence map›Paper›PMID 42433677›Full record

ReviewFrontiers in aging2026

From molecular damage to regulatory constraint: epigenetic and metabolic limits of cellular plasticity in aging.

Antoni R Godlewski, Tomasz Dziaman

Abstract readReview
In one paragraph

Review in Frontiers in aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Antoni R GodlewskiDepartment of Clinical Biochemistry, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Bydgoszcz, Poland.
Tomasz DziamanDepartment of Clinical Biochemistry, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Bydgoszcz, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aging is most often portrayed as the progressive buildup of molecular damage, yet this conventional view leaves much unexplained. Over time, cells and tissues appear to lose the regulatory flexibility that allows them to adapt, repair, and reconfigure their functional states. Genomic instability, metabolic imbalance, mitochondrial dysfunction, and proteostatic decline converge on aging, but their effects focus on chromatin organization, transcriptional coordination, and signaling networks that maintain cellular identity. In this review, we propose that aging can be usefully viewed as a progressive restriction of epigenetic and regulatory plasticity, rather than as the simple accumulation of lesions. Pathways such as Wnt signaling, TET-dependent DNA demethylation, and metabolic sensors including AMPK, mTOR, and sirtuins create an interconnected landscape that links environmental and metabolic conditions with long-term cellular behavior. As this landscape becomes increasingly rigid and constrained, cells retain viability but lose their capacity for dynamic responses, stabilizing in low-plasticity states that include cellular senescence. Framing aging as a shift from adaptive plasticity toward regulatory rigidity offers a possible integrative lens on classical hallmarks and epigenetic aging signatures, without replacing existing models. Rather than targeting individual hallmarks in isolation, future approaches may need to complement hallmark-focused strategies by restoring dynamic balance within epigenetic and signaling networks that preserve tissue-level homeostasis and regenerative potential, thereby suggesting specific, testable predictions for interventions acting on metabolic-epigenetic axes.

Indexed as

agingcellular senescenceepigenetic agingepigenetic plasticitymetabolismregulatory networksTET dioxygenasesWnt signaling

Identifiers

PMID42433677
PMCPMC13350435

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.